These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 19895739)
21. Monoclonal antibody Adnab-9 defines a preneoplastic marker in epithelium at risk for adenocarcinoma of the small intestine. Tobi M; Kaila V; Hassan N; Gallinger S; Fligiel S; Hatfield J; Gesell M; Sakr W; Luk G; Odze RD Hum Pathol; 1999 Apr; 30(4):467-73. PubMed ID: 10208470 [TBL] [Abstract][Full Text] [Related]
22. Increased levels of promutagenic etheno-DNA adducts in colonic polyps of FAP patients. Schmid K; Nair J; Winde G; Velic I; Bartsch H Int J Cancer; 2000 Jul; 87(1):1-4. PubMed ID: 10861445 [TBL] [Abstract][Full Text] [Related]
23. Enhanced cyclooxygenase-2 expression in sporadic and familial adenomatous polyposis of the human colon. Khan KN; Masferrer JL; Woerner BM; Soslow R; Koki AT Scand J Gastroenterol; 2001 Aug; 36(8):865-9. PubMed ID: 11495083 [TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of eflornithine (CPP-1X)/sulindac combination therapy versus each as monotherapy in patients with familial adenomatous polyposis (FAP): design and rationale of a randomized, double-blind, Phase III trial. Burke CA; Dekker E; Samadder NJ; Stoffel E; Cohen A BMC Gastroenterol; 2016 Aug; 16(1):87. PubMed ID: 27480131 [TBL] [Abstract][Full Text] [Related]
25. Flow cytometric analysis of DNA synthetic phase fraction of the normal appearing colonic mucosa in patients with colorectal neoplasms. Nakamura S; Goto J; Kitayama Y; Sheffield JP; Talbot IC Gut; 1995 Sep; 37(3):398-401. PubMed ID: 7590437 [TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical characteristics of duodenal adenomas in familial adenomatous polyposis with special reference to cell kinetics. Esaki M; Matsumoto T; Yao S; Nakamura S; Hirahashi M; Yao T; Iida M Hum Pathol; 2005 Jan; 36(1):66-73. PubMed ID: 15712184 [TBL] [Abstract][Full Text] [Related]
27. Genomic and transcriptomic profiling of carcinogenesis in patients with familial adenomatous polyposis. Li J; Wang R; Zhou X; Wang W; Gao S; Mao Y; Wu X; Guo L; Liu H; Wen L; Fu W; Tang F Gut; 2020 Jul; 69(7):1283-1293. PubMed ID: 31744909 [TBL] [Abstract][Full Text] [Related]
28. Cell proliferation and apoptotic indices predict adenoma regression in a placebo-controlled trial of celecoxib in familial adenomatous polyposis patients. Sinicrope FA; Half E; Morris JS; Lynch PM; Morrow JD; Levin B; Hawk ET; Cohen DS; Ayers GD; Stephens LC; Cancer Epidemiol Biomarkers Prev; 2004 Jun; 13(6):920-7. PubMed ID: 15184247 [TBL] [Abstract][Full Text] [Related]
29. Microenvironmental changes in familial adenomatous polyposis during colorectal cancer carcinogenesis. Hisano K; Mizuuchi Y; Ohuchida K; Kawata J; Torata N; Zhang J; Katayama N; Tsutsumi C; Nakamura S; Okuda S; Otsubo Y; Tamura K; Nagayoshi K; Ikenaga N; Shindo K; Nakata K; Oda Y; Nakamura M Cancer Lett; 2024 May; 589():216822. PubMed ID: 38521200 [TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical expression of PCNA and CD34 in colorectal adenomas and carcinomas using specified automated cellular image analysis system: a clinicopathologic study. Qasim BJ; Ali HH; Hussein AG Saudi J Gastroenterol; 2012; 18(4):268-76. PubMed ID: 22824771 [TBL] [Abstract][Full Text] [Related]
31. Complete reversion and prevention of rectal adenomas in colectomized patients with familial adenomatous polyposis by rectal low-dose sulindac maintenance treatment. Advantages of a low-dose nonsteroidal anti-inflammatory drug regimen in reversing adenomas exceeding 33 months. Winde G; Schmid KW; Schlegel W; Fischer R; Osswald H; Bünte H Dis Colon Rectum; 1995 Aug; 38(8):813-30. PubMed ID: 7634976 [TBL] [Abstract][Full Text] [Related]
32. [Expression and significance of APC, beta-catenin, C-myc, and Cyclin D1 proteins in colorectal carcinoma]. Dai WB; Ren ZP; Chen WL; DU J; Shi Z; Tang DY Ai Zheng; 2007 Sep; 26(9):963-6. PubMed ID: 17927853 [TBL] [Abstract][Full Text] [Related]
33. Expression of COX-2 and Wnt pathway genes in adenomas of familial adenomatous polyposis patients treated with meloxicam. Dobbie Z; Muller PY; Heinimann K; Albrecht C; D'Orazio D; Bendik I; Müller H; Bauerfeind P Anticancer Res; 2002; 22(4):2215-20. PubMed ID: 12174906 [TBL] [Abstract][Full Text] [Related]